TPMT Assessment Prior to Initiation of Thiopurine Therapy: Results and the Impact of TPMT on Starting Dose

被引：0
作者：
Wysocki, John [1 ]
Mehmood, Faisal [2 ]
Khan, Nabeel [3 ]
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[2] Univ Penn, Dept Gastroenterol, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01955
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1955
引用
收藏
页码：S828 / S828
页数：1
相关论文
共 50 条
  • [41] Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment
    Wormser, Gary P.
    McKenna, Donna
    Jacobson, Eliana
    Shanker, Elayna M.
    Shaffer, Keith D.
    Scavarda, Carol
    Visintainer, Paul
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [42] Low dose thiopurine and allopurinol co-therapy results in significant cost savings at a district general hospital
    Dharmasiri, Suranga
    Dewhurst, Hannah
    Johnson, Heather
    Weaver, Sean
    McLaughlin, Simon
    FRONTLINE GASTROENTEROLOGY, 2015, 6 (04) : 285 - 289
  • [43] Initiation Dose of Sodium Valproate in Epilepsy: Proof of Concept Study of the Impact of Starting Dose and Titration on Seizure Control and Side Effect Profile
    Goei, A. H. Y.
    Chan, D.
    Ghosh, P.
    Chakraborty, B.
    EPILEPSIA, 2018, 59 : S71 - S72
  • [44] Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease
    Nawaz, Ahmad
    Glick, Laura R.
    Chaar, Abdelkader
    Li, Darrick K.
    Gaidos, Jill K. J.
    Proctor, Deborah D.
    Al-Bawardy, Badr
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (01): : 39 - +
  • [45] Low-Dose Thiopurine and Allopurinol Co-Therapy Results in Significant Cost Savings At a District General Hospital
    Johnson, Heather E.
    Dewhurst, Hannah M.
    Weaver, Sean
    McLaughlin, Simon D.
    GASTROENTEROLOGY, 2013, 144 (05) : S777 - S777
  • [46] Alteplase dose assessment for pleural infection therapy (ADAPT) study-3: A starting intrapleural dose of 1 mg alteplase
    Lau, E.
    Donaghy, M.
    Faber, S.
    Krivinskas, S.
    Fysh, E.
    Vekaria, S.
    Lee, Y.
    RESPIROLOGY, 2024, 29 : 66 - 66
  • [47] Alteplase dose assessment for pleural infection therapy (ADAPT) study-3: A starting intrapleural dose of 1 mg alteplase
    Lau, Estee Pui Mun
    Donaghy, Michaela
    Faber, Sam
    Krivinskas, Sophie
    Vekaria, Sona
    Lee, Yun Chor Gary
    RESPIROLOGY, 2023, 28 : 82 - 83
  • [48] Long-term outcome of the DECREASE III trial; the impact of initiation of statin therapy prior to surgery
    Schouten, O.
    Hoeks, S. E.
    Boersma, H.
    Voute, M. T.
    Ravensbergen, N.
    Goncalves, F. Bastos
    Van De Luitgaarden, K.
    Bax, J. J.
    Verhagen, H. J. M.
    Poldermans, D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 332 - 333
  • [49] IMPACT OF TIME TO INITIATION OF STRESS-DOSE STEROIDS ON VASOPRESSOR THERAPY DURATION IN SEPTIC SHOCK
    Tednes, Patrick
    Chang, Kevin
    Chaney, Whitney
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 763 - 763
  • [50] Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose
    Popowicz, Natalia
    Ip, Hugh
    Lau, Estee P. M.
    Piccolo, Francesco
    Dootson, Kirstie
    Yeoh, Cindy
    Phu, Wint Ywe
    Brown, Rebecca
    West, Alex
    Ahmed, Liju
    Lee, Y. C. Gary
    RESPIROLOGY, 2022, 27 (07) : 510 - 516
12345